Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 5/2013

01-05-2013 | Letter to Editor

Pre-conceptional exposure to rituximab: comment on the article by Ojeda-Uribe et al.

Authors: Roberta Gualtierotti, Francesca Ingegnoli, Pier Luigi Meroni

Published in: Clinical Rheumatology | Issue 5/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Ojeda-Uribe M, Afif N, Dahan E, Sparsa L, Haby C, Sibilia J, Ternant D, Ardizzone M (2013) Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases. Clin Rheumatol. doi:10.​1007/​s10067-012-2156-4
2.
Chakravarty EF, Murray ER, Kelman A, Farmer P (2011) Pregnancy outcomes after maternal exposure to rituximab. Blood 117:1499–1506PubMedCrossRef
3.
Ton E, Tekstra J, Hellmann PM, Nuver-Zwart IH, Bijlsma JW (2011) Safety of rituximab therapy during twins’ pregnancy. Rheumatology 50:806–808PubMedCrossRef
4.
5.
Jain V, Gordon C (2011) Managing pregnancy in inflammatory rheumatological diseases. Arthritis Res Ther 13:206PubMedCrossRef
6.
de Man YA, Hazes JM, van der Heide H, Willemsen SP, de Groot CJ, Steegers EA et al (2009) Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 60:3196–3206PubMedCrossRef
7.
Chakravarty EF, Nelson L, Krishnan E (2006) Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54:899–907PubMedCrossRef
8.
Costedoat-Chalumeau N, Amoura Z, Villain E, Cohen L, Piette JC (2005) Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther 7:69–73PubMedCrossRef
Metadata
Title
Pre-conceptional exposure to rituximab: comment on the article by Ojeda-Uribe et al.
Authors
Roberta Gualtierotti
Francesca Ingegnoli
Pier Luigi Meroni
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2241-3

Other articles of this Issue 5/2013

Clinical Rheumatology 5/2013 Go to the issue

Case Based Review

Giant iliopectineal bursitis presenting as neuropathy and severe edema of the lower limb: case illustration and review of the literature

Case Based Review

Felty's syndrome without rheumatoid arthritis?

Brief Report

A predictive model for remission and low disease activity in patients with established rheumatoid arthritis receiving TNF blockers

Original Article

Identification of transcription regulatory relationships in rheumatoid arthritis and osteoarthritis

Review Article

Genistein: the potential for efficacy in rheumatoid arthritis

Original Article

An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits